Covidien's Nellcor ventillators have been burdened with another Class I recall due to a manufacturing mishap.
Medtronic's shareholders overwhelmingly approve its $43 billion merger with Covidien, setting the stage for the deal to close in a few weeks.
Covidien says shareholders at a meeting in Ireland this morning approved its pending, $43 billion merger with Medtronic.
Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: Stryker could move for Smith & Nephew 'soon'; Zoll Medical to acquire Advanced Circulatory Systems; Judge won't stop Medtronic plan to cover $63m tax tab for execs, directors; Covidien inks deal to settle lawsuit over Medtronic merger; Medtech M&A: Uroplasty, Vision-Sciences to merge
Covidien agrees to a deal that would settle a consolidated derivatives lawsuit filed by shareholders looking to block its $43 billion merger with Medtronic.
A Minnesota federal judge declines to stop Medtronic's plan to cover a $63 million tax tab stemming from its Covidien buyout for its top executives and directors.
There was a significant amount of turnover this year in the corner offices of medical device companies, including exits by some of medtech's biggest names.
There was a revolving door on medtech's corner office this year, with more than 35 CEOs leaving their positions through planned transitions, retirement or termination, according to a MassDevice.com analysis.